Author:
Braunlin William,Zhorov Eugene,Guo Amy,Apruzzese William,Xu Qiuwei,Hook Patrick,Smisek David L.,Mandeville W. Harry,Holmes-Farley S. Randall
Reference26 articles.
1. RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers;Burke;Nephrol Dial Transplant,1997
2. Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure;Chertow;Am J Kidney Dis,1997
3. Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients;Chertow;Nephrol Dial Transplant,1999
4. A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients;Chertow;Clin Nephrol,1999
5. Effect of RenaGel, a non-absorbed, calcium- and aluminum-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients;Goldberg;Nephrol Dial Transplant,1998
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献